Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06500338 · ClinicalTrials.gov registry record · NA
Determining the Dose Response Profile of the Headward Fluid Shift During Varying Gravity Levels
A NA study, sponsored by National Aeronautics and Space Administration (NASA).
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT06500338 is a NA study that has completed, run by National Aeronautics and Space Administration (NASA). The registered enrollment target is 9 participants.
The verdict
NCT06500338, a NA study, has completed, sponsored by National Aeronautics and Space Administration (NASA).
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Parabolic flight provides a unique opportunity to evaluate the acute changes associated with varying levels of gravity and to describe how key venous parameters change at levels less than normal Earth gravity. Characterizing these changes in response to varying G-levels is an important step in determining what G-level may be required to reverse weightlessness-induced fluid shifts and thus serve as a viable countermeasure during long-duration spaceflight. Further, these results will inform National Aeronautics and Space Administration (NASA) whether there might be a lower risk of Spaceflight Associated Neuro-ocular Syndrome (SANS) and Venous Thromboembolism (VTE) during extended stays on the Moon and Mars.
Interventions
- PROCEDURE free-fall
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2024-04-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06500338
The ClinicalTrials.gov registry entry for NCT06500338 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Aeronautics and Space Administration (NASA), which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which free-fall is the first listed.
NCT06500338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06500338 about?
NCT06500338 is a clinical study titled "Determining the Dose Response Profile of the Headward Fluid Shift During Varying Gravity Levels". Parabolic flight provides a unique opportunity to evaluate the acute changes associated with varying levels of gravity and to describe how key venous parameters change at levels less than normal Earth gravity. Characterizing these changes in response to varying G-levels is an important step in deter...
What is the current status of trial NCT06500338?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2022-07-21. Estimated completion is 2024-04-17.
What interventions are being tested in trial NCT06500338?
The interventions under investigation include: free-fall (PROCEDURE).
Who is sponsoring clinical trial NCT06500338?
This trial is sponsored by National Aeronautics and Space Administration (NASA), which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.